Please do not leave this page until complete. This can take a few moments.
Financial technology, or fintech, is an industry used globally every day, but typically goes unnoticed.
Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors,
Framingham-based Trilio, a provider of data protection for cloud-native environments, announced Wednesday its latest ransomware protection with the release of TrilioVault for Kubernetes.
Marlborough diagnostic company Immunovia, Inc. announced on Monday it has acquired a global license from the South Korean company JW BioScience’s intellectual property portfolio, granting Immunovia global commercial rights for two biomarkers.
The homogeneity among news editorship in Central Massachusetts is not unique to the region, but it does bring with it inherent questions about who decides what stories are newsworthy, and who decides how they are told.
Even though the LGBTQ+ community represents a significant portion of the Central Massachusetts population, the number of owners who identify their businesses as such remains low.
Marlborough company Sunovion Pharmaceuticals announced on Thursday it granted exclusive commercial license rights in Europe to Portugese company Bial for Sunovion's KYNMOBI, an under-the-tongue drug treating OFF episodes in patients with Parkinson’s
Arch Therapeutics, a Framingham biotechnology company specializing in wound care and biosurgical devices, announced Thursday a partnership with Lovell Government Services, a Floridia medical supply distributor.
Framingham biotech company SCIEX on Wednesday announced the launch of two new initiatives, a software and a capillary electrophoresis system.
Pillar Biosciences in Natick announced on Wednesday the appointment of Randy Pritchard as CEO, as the company’s founder and previous CEO Dr. Gang Song will transition to the role of chairman of the board, according to a press release.
HebeCell Corp., a Natick research company focused on therapies for cancer and autoimmune disease, announced on Tuesday it has closed a $53-million Series A financing for an off-the-shelf stem cell product.
Marlborough medical device manufacturer Boston Scientific Corp. acquired Lumenis, an Israel-based surgical company specializing in urological lasers, in a $1.1-billion deal announced on Wednesday.
Tech repair provider uBreakiFix opened its newest franchise location in Milford at the 124 Medway Road plaza according to a Monday announcement.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company in Worcester, reported a net loss of $14.4 million for the company’s second quarter in an earnings report released last Monday.
The new program at UMass Memorial Health offers hospital-level care to patients in their own homes, using virtual monitoring systems and at-home visits from healthcare professionals.
IPG Photonics, a laser manufacturing company based in Oxford, purchased two properties, one for $5.8 million and one for $2 million, next to its Marlborough warehouses on Cedar Hill Street.